FeesSafety
Pluang+

Ethereum's quantum-resistant zkVM tool leanVM is fully verified, with a 2028 target for full network upgrade.

Protocol Fundamentals
03 Nov 2026, 23:31 WIB
Crypto Briefing
View Source
Bullish
Ethereum's quantum-resistant zkVM tool leanVM is fully verified, with a 2028 target for full network upgrade.

Ethereum has achieved end-to-end formal verification of leanVM, a minimal zero-knowledge virtual machine designed to aggregate post-quantum signatures efficiently. This milestone is part of Ethereum's plan to transition its network to quantum-resistant cryptography by December 2028, replacing current BLS signatures with hash-based leanXMSS signatures at the consensus layer. The formal verification ensures the tool behaves exactly as specified, enhancing security against future quantum threats. The transition will involve multiple coordinated network upgrades, giving developers and validators a clear timeline to prepare.

Ethereum's leanVM formal verification is the subject, with Pluang market data providing context as of Nov 04, 2026 04:25 WIB: Among 50 major cryptocurrencies priced on Pluang, 37 rose and 12 fell today. Notable movers include UNI at Rp131.063 (+2.86%, 55% Sell / 45% Buy), SOL at Rp1.703.992 (+2.54%, 39% Sell / 61% Buy), and XTZ at Rp4.517 (+2.52%, 0% Sell / 100% Buy). The most notable figure is XTZ's 100% buy order activity on Pluang.

More News

Kelly Technology + Motion Recruitment named Leader by Everest Group for US IT staffing and consulting excellence

Kelly Technology + Motion Recruitment named Leader by Everest Group for US IT staffing and consulting excellence

Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...

Market News
Bullish
1 hour ago
Sutro Biopharma to present at multiple investor conferences in November and December 2026

Sutro Biopharma to present at multiple investor conferences in November and December 2026

Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...

Market News
Neutral
2 hours ago
etoro acquires Argentine fintech LB Finanzas to expand in Latin America

etoro acquires Argentine fintech LB Finanzas to expand in Latin America

etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...

Company Fundamentals
Bullish
2 hours ago
JD.com to release Q3 2026 financial results on Nov 17 with a management call scheduled.

JD.com to release Q3 2026 financial results on Nov 17 with a management call scheduled.

JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...

Company Fundamentals
Neutral
5 hours ago
KE Holdings to release Q3 2026 financial results on Nov 16 with a live earnings call.

KE Holdings to release Q3 2026 financial results on Nov 16 with a live earnings call.

KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...

Company Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App